Clinical trial

A Study of HIV-Disease Development in Aging

NCT00006144

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2000-10-01

PhasePHASE2

Study timeline

Study start (unknown)2000-10-01Date precision: month

Registry last updated2021-11-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Lopinavir/RitonavirDRUG

EmtricitabineDRUG

StavudineDRUG

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Mapped research locations

New YorkNew York, United States5 BostonMassachusetts, United States4 IndianapolisIndiana, United States3 RochesterNew York, United States3 ChicagoIllinois, United States2 PhiladelphiaPennsylvania, United States2 ClevelandOhio, United States2 ProvidenceRhode Island, United States2 HonoluluHawaii, United States2 Los AngelesCalifornia, United States1 DallasTexas, United States1 BaltimoreMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00006144 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.